Science         
06 July 2018  Vol 361, Issue 6397
http://www.sciencemag.org/current.dtl

Is FDA’s revolving door open too wide?
By Charles Piller
Science06 Jul 2018 : 21 Restricted Access
Many FDA staff overseeing drug reviews end up working for makers of those drugs